Novel online calculator to predict reduced risk of early recurrence from adjuvant transarterial chemoembolisation for patients with hepatocellular carcinoma
Wei-Yue Chen(Second Military Medical University), Yongyi Zeng(Sun Yat-sen University), Qing-Yu Kong(Nantong University), Yingjian Liang(Harbin Medical University), Wan Yee Lau(Chinese University of Hong Kong), Timothy M. Pawlik(The Ohio State University), Lan‐Qing Yao(Second Military Medical University), Zixiang Chen(Anhui Medical University), Chao Li(Second Military Medical University), Zhi-Peng Liu(Army Medical University), Feng Shen(Second Military Medical University), Li‐Yang Sun(Unknown), Ya-Hao Zhou(Puer University), Ting‐Hao Chen(National Taiwan University), Jiansong Ji(Wenzhou Medical University), Ming-Da Wang(Second Military Medical University)
Cited by 12
Related Papers
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Metal-Polydopamine Framework: An Innovative Signal-Generation Tag for Colorimetric Immunoassay
|Analytical Chemistry|2018|349